Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study

UPARAREMUS is the first study evaluating the efficacy of upadacitinib in reaching both clinical and US remission in patients with RA. At 24 weeks, 63.6% of patients reached the primary endpoint, the only baseline associated parameter was being bio-naïve.

Authors

Institutions

Publication Details

Journal
Rheumatology and Therapy
Published
2024-08-23
DOI
https://doi.org/10.1007/s40744-024-00712-y
Citations
8
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
3.76

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study

Simonetta Salemi, Caterina Baldi, Bruno Frediani, Roberta Rosa et al.
8 citations
Rheumatology and Therapy
Rheumatoid Arthritis Research and Therapies
3.76
article

Clinical and Ultrasonographic Remission in Bio-naïve and Bio-failure Patients with Rheumatoid Arthritis at 24 Weeks of Upadacitinib Treatment: The UPARAREMUS Real-Life Study

Simonetta Salemi, Caterina Baldi, Bruno Frediani, Roberta Rosa, Maria Sofia Cattaruzza, Andrea Picchianti Diamanti, Gian Domenico Sebastiani, Maria Sole Chimenti, Marco Canzoni, Chiara De Lorenzo, Ivan Giovannini, Valentino Paci, Chiara Scirocco, Annamaria Iagnocco, Alen Zabotti, Michele Maria Luchetti, Bruno Laganà, Arianna D’Antonio, Giorgio Sesti, Carlo Perricone, Gloria Maria Felice, G. Crepaldi
article en
8 citations

Abstract

UPARAREMUS is the first study evaluating the efficacy of upadacitinib in reaching both clinical and US remission in patients with RA. At 24 weeks, 63.6% of patients reached the primary endpoint, the only baseline associated parameter was being bio-naïve.

Rheumatology and TherapyVol. 11(5)
University of Siena (IT), University of Rome Tor Vergata (IT), Marche Polytechnic University (IT), University of Udine (IT), University of Perugia (IT), Ospedale Santa Maria della Misericordia di Udine (IT), Ospedale Regina Margherita (IT), University of Turin (IT), Sapienza University of Rome (IT)
AbbVie
Openalex Percentile: Top 7%
Rheumatoid Arthritis Research and Therapies
3.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.